Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy

Yimou Gong,Muchao Chen,Yanjun Tan,Jingjing Shen,Qiutong Jin,Wutong Deng,Jian Sun,Chao Wang,Zhuang Liu,Qian Chen

DOI: https://doi.org/10.1021/acsami.0c13943

2020-11-02

Abstract:Chemotherapeutic agents have been widely used for cancer treatment in clinics. Aside from their direct cytotoxicity to cancer cells, some of them could activate the immune system of the host, contributing to the enhanced antitumor activity. Here, the reactive oxygen species (ROS)-responsive hydrogel, covalently cross-linked by phenylboronic acid-modified 7-ethyl-10-hydroxycamptothecin (SN38-SA–BA) with poly(vinyl alcohol) (PVA), is fabricated for topical delivery of anti-programmed cell death protein ligand 1 antibodies (aPDL1). In the presence of endogenous ROS, SN38-SA–BA will be oxidized and hydrolyzed, leading to the degradation of hydrogel and the release of initial free SN38 and encapsulated aPDL1. It is demonstrated that SN38 could elicit specific immune responses by triggering immunogenic cell death (ICD) of cancer cells, a distinct cell death pathway featured with the release of immunostimulatory damage-associated molecular patterns (DAMPs). Meanwhile, the released aPDL1 could bind to programmed cell death protein ligand 1 (PDL1) expressed on cancer cells to augment antitumor T cell responses. Thus, the ROS-responsive prodrug hydrogel loaded with aPDL1 could induce effective innate and adaptive antitumor immune responses after local injection, significantly inhibiting or even eliminating those tumors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c13943?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c13943</a>.Synthesis route of SN38-SA–BA (Scheme S1); gelation of different proportions among PVA, SN38-SA-BA, and PEG800 (Table S1); in situ ¹H NMR spectra of SN38-SA-BA (BP) (Figure S1); fabrication of PVA-SN38 hydrogel (Figure S2); immune responses induced by PVA-SN38 hydrogel in vivo (Figure S3); percentage of CD8⁺ T cells and CD4⁺ T cells (Figure S4); biocompatibility of PVA-SN38 hydrogel in vivo (Figure S5); ¹H and ¹³C NMR spectra of synthesized compounds (Figures S6–S14); and electrospray ionization high-resolution mass spectra (Figures S15–S18) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c13943/suppl_file/am0c13943_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

materials science, multidisciplinary,nanoscience & nanotechnology